Sm Surgicals & Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Revenue -42.58%
(FY 2021)
- Profit -84.64%
(FY 2021)
- Ebitda -39.51%
(FY 2021)
- Net Worth 3.83%
(FY 2021)
- Total Assets 28.24%
(FY 2021)
About Sm Surgicals & Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manoranjan Sahoo and Saibalini Sahoo serve as directors at the Company.
- CIN/LLPIN
U74900OR2013PTC017321
- Company No.
017321
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2013
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Jagatsinghapur, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sm Surgicals & Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoranjan Sahoo  | Director | 05-Sep-2013 | Current |
| Saibalini Sahoo | Director | 05-Sep-2013 | Current |
Financial Performance of Sm Surgicals & Pharmaceuticals.
Sm Surgicals & Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 42.58% decrease. The company also saw a substantial fall in profitability, with a 84.64% decrease in profit. The company's net worth moved up by a moderate rise of 3.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sm Surgicals & Pharmaceuticals?
In 2021, Sm Surgicals & Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mgs Chemicals India Private LimitedActive 13 years 6 monthsManoranjan Sahoo and Saibalini Sahoo are mutual person
- Mellows Infra Projects Private LimitedActive 4 years 7 months
Manoranjan Sahoo and Saibalini Sahoo are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sm Surgicals & Pharmaceuticals?
Unlock and access historical data on people associated with Sm Surgicals & Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sm Surgicals & Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sm Surgicals & Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
